Despite guidelines addressing overdetection, no significant declines are seen; emphasis on active surveillance approaches is ...

Overdiagnosis of thyroid cancer in the United States remains a persistent problem, according to a study published online Feb.

Noah S. Kalman, MD, MBA, discusses the evolving role of molecular and genetic testing in thyroid cancer management.

HealthDay News — The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, ...

Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to results from a retrospective, population-based study.

Thyroid cancer continues to be overdiagnosed, though the survival rate remains unchanged, according to a study published Feb. 5 in The Lancet Diabetes & Endocrinology. Here are five notes from the ...

In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...

Follicular thyroid cancer with bone involvement was associated with a significantly elevated risk for brain metastases among women.

Thyroid cancer is typically first noticed as a thyroid nodule. The symptoms may be the same for both, but females are more likely to get thyroid cancer than men. (Photo Credit: Sebastian Kaulitzki ...

the cancer stage, and a person’s overall health. The current survival rates are highest for thyroid cancer, prostate cancer, testicular cancer, and melanoma. The survival rate for early-stage ...